Elephantiasis: A Chronic Disease Linking Mosquitoes, Filarial Worms, and the Breakdown of the Lymphatic System

Elephantiasis is a chronic disease manifestation most commonly caused by lymphatic filariasis. It is characterized by the progressive enlargement of affected body parts, thickening of the skin and underlying tissues, heaviness, disfigurement, and, eventually, impairment of mobility and appearance.

Illustration showing enlarged feet in a patient with elephantiasis（Image source：James Newton，CC0 1.0 ）

Illustration showing scrotal swelling in a patient with elephantiasis（Image source：Internet Archive Book Images，CC0 1.0 ）

Lymphatic filariasis is a mosquito-borne parasitic disease caused mainly by three onchocercid nematodes: Wuchereria bancrofti, Brugia malayi, and Brugia timori. Among them, W. bancrofti accounts for approximately 90% of cases worldwide, making it the most frequently discussed species. Adult worms live in the human lymphatic system, where they can cause lymphedema, hydrocele, and recurrent attacks of acute adenolymphangitis. Not all forms of elephantiasis are caused by filarial infection. Non-filarial elephantiasis has been associated with irritating soil particles in volcanic soils and may also arise in connection with tuberculosis, leprosy, leishmaniasis, recurrent streptococcal infections, or sexually transmitted infections such as lymphogranuloma venereum. In the global public health context, however, lymphatic filariasis remains the central concern.

Wuchereria bancrofti, stained with hematoxylin（Image source：CDC，CC0 1.0 ）

Brugia malayi, stained with hematoxylin（Image source：CDC，CC0 1.0 ）

The infection begins when a mosquito carrying infective third-stage filarial larvae bites a human host. The larvae enter the skin and migrate to the lymphatic vessels and lymph nodes, where they develop into adult worms. Male and female worms mate within the lymphatic system, after which the female releases sheathed microfilariae into the host. These microfilariae enter the lymph and peripheral blood circulation. When another mosquito takes a blood meal from the infected person, it ingests the microfilariae. Inside the mosquito, the microfilariae lose their sheath, penetrate the midgut, and migrate to the thoracic muscles, where they develop from first-stage larvae into infective third-stage larvae. They then move toward the mosquito's head and proboscis, ready to enter the next human host during a subsequent blood meal.

Life cycle of Wuchereria bancrofti; the life cycle of Brugia spp. is similar（Image source：CDC，CC0 1.0 ）

The lymphatic vessels are responsible for returning tissue fluid, maintaining immune surveillance, and preserving local fluid balance. Once they are repeatedly affected by parasitism, inflammation, and obstruction, fluid can begin to accumulate within tissues. At first, swelling may be intermittent; over time, it can progress into persistent lymphedema. As the disease advances, the skin thickens, fibrosis increases, and local immune defenses become weaker, making affected tissues more vulnerable to recurrent infection by opportunistic microorganisms. Each episode of acute adenolymphangitis can further damage lymphatic structure and function. Swelling and inflammation then reinforce each other, gradually producing the clinical features recognized as elephantiasis.

Schematic diagram of the lymphatic system（Image source：Cancer Research UK， CC BY-SA 4.0 ）

Recent research has clarified the mechanism of this disease by focusing on a group of intracellular endosymbiotic bacteria belonging to the genus Wolbachia. These bacteria are important for the development, reproduction, and long-term survival of many filarial nematodes. They are found mainly in vacuoles within the germline and somatic cells of the worms and can be transmitted vertically through the eggs to the next generation. From the perspective of the human host, when parasites moult, die, continuously release microfilariae, or are damaged by antifilarial drugs, molecules produced by Wolbachia can be released and stimulate the host innate immune system, triggering inflammatory responses. Elephantiasis, therefore, is not simply the result of filarial worms mechanically blocking lymphatic vessels. Immune activation, lymphatic injury, secondary infection, and tissue remodeling all contribute to the development of this chronic disease.

Cross-section of Brugia malayi showing Wolbachia endosymbionts in the lateral cords (LC) and ovary (O), indicated by red staining (immunostaining)（Image source：Slatko BE et al. (2010)， CC BY-NC 2.0 ）

Treatment and control operate on two levels. The first is interruption of community transmission, mainly through mass drug administration. Commonly used drugs include albendazole, sometimes in combination with ivermectin. Another regimen combines albendazole with diethylcarbamazine citrate. In recent years, triple-drug therapy has also been used. The purpose of these regimens is to reduce the number of microfilariae and infectious reservoirs within the community, making it less likely that mosquitoes will transmit the parasites to another person. Data from multiple endemic areas show that sustained rounds of mass drug administration can reduce infection indicators. However, true control depends on drug coverage, community acceptance, healthcare infrastructure, and surveillance capacity.

The second level concerns people who already live with chronic disease. For these patients, interrupting transmission is still important, but their daily reality is shaped by swollen body parts, recurrent infection, pain, difficulty moving, and social exclusion. Disease management therefore cannot focus only on whether the parasite has disappeared. It must also include lymphedema care, prevention of disability, management of hydrocele, and reduction of acute inflammatory attacks. Studies in some regions have also shown that community beliefs about the cause of the disease can influence health-seeking behavior. When people attribute the condition to animal feces, witchcraft, or other non-medical causes, treatment may be delayed, and patients may rely more heavily on traditional healers. Effective control must therefore address knowledge, trust, and access to care at the same time.

Recent therapeutic thinking has also turned Wolbachia into an important target. Antibiotics such as doxycycline can deplete Wolbachia, and anti-Wolbachia treatment has been reported to reduce scrotal lymphatic vessel enlargement in patients infected with W. bancrofti. Similar effects have also been linked to interference with parasite reproduction. In addition, genomic studies now allow researchers to screen proteins and metabolic pathways of Wolbachia for potential drug targets, including outer membrane proteins and enzymes involved in nucleotide and cell-wall-related metabolism. These approaches may make future treatment more specific and biologically targeted.

Author: Shui-Ye You

References:

1. Jian H et al. (2026). Global Lymphatic Filariasis Post-Validation Surveillance Activities in 2025: A Scoping Review. Trop Med Infect Dis.

2. Lamula SQ et al. (2024). Prevalence of elephantiasis, an overlooked disease in Southern Africa: a comprehensive review. J Venom Anim Toxins Incl Trop Dis.

3. Setegn A et al. (2024). Wolbachia and Lymphatic Filarial Nematodes and Their Implications in the Pathogenesis of the Disease. J Parasitol Res.

4. Slatko BE et al. (2010). The Wolbachia endosymbiont as an anti-filarial nematode target. Symbiosis.